Ritu Roy

Ritu Roy is a researcher affiliated with the University of California, San Francisco (UCSF) School of Medicine and the HDF Comprehensive Cancer Center. Her work spans oncology, genomics, and bioinformatics, with a focus on biomarker discovery, tumor heterogeneity, and translational research.

Research Interests:

• Genomic and epigenetic drivers in cancers (leukemia, breast, pancreatic, and head/neck cancers)
• Development of predictive models for treatment response and disease progression
• Single-cell and multiomic approaches to characterize molecular heterogeneity
• Integration of clinical data with pathway analysis for neurodegenerative-cancer intersections

Publications: Her recent work includes studies on symptom clusters in chemotherapy patients, computational tools for eQTM mapping, and genomic profiling of circulating tumor cells. Key trends involve breast cancer, leukemia, and epigenetic modifications.

Laboratory & Collaborations: Affiliated with the HDF Comprehensive Cancer Center at UCSF, she collaborates on clinical trials like I-SPY and CALGB, leveraging high-throughput sequencing and bioinformatics for precision oncology.